Article
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
International Journal of Chronic Obstructive Pulmonary Disease · 2021 · Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P
Key facts
| Title | Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO |
|---|---|
| First author | Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P |
| Journal | International Journal of Chronic Obstructive Pulmonary Disease |
| Published | Jun 16, 2021 |
| DOI | 10.2147/COPD.S294333 |
| Devices mentioned | 201108, 207577 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1